Literature DB >> 12734859

Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients.

S G Frederiksen1, J L Hedenbro, L Norgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12734859     DOI： 10.1002/bjs.4068

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  22 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  [Bleeding complications in bariatric surgery: Prophylaxis and therapy].

Authors:  H Spieker; A Dietrich
Journal:  Chirurg       Date:  2015-09       Impact factor: 0.955

Review 3.  Prevention of venous thromboembolism in obesity.

Authors:  Andrew L Freeman; Robert C Pendleton; Matthew T Rondina
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-12

4.  Identifying the Bariatric Patient at Risk for Pulmonary Embolism: Prospective Clinical Trial Using Duplex Sonography and Blood Screening.

Authors:  Sebastian W Holländer; Alfred Sifft; Sarah Hess; Hans Joachim Klingen; Peter Djalali; Dieter Birk
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 5.  Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.

Authors:  Jeremy W Vandiver; Leticia I Ritz; Jeffrey T Lalama
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

6.  Post discharge prophylactic anticoagulation in gastric bypass patient-how safe?

Authors:  Peter Ojo; Bolanle Asiyanbola; Elmer Valin; Randolph Reinhold
Journal:  Obes Surg       Date:  2008-04-03       Impact factor: 4.129

7.  Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.

Authors:  Matthew T Rondina; Michelle Wheeler; George M Rodgers; Leslie Draper; Robert C Pendleton
Journal:  Thromb Res       Date:  2009-03-09       Impact factor: 3.944

Review 8.  Mechanisms of thrombosis in obesity.

Authors:  Ilya O Blokhin; Steven R Lentz
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

9.  Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.

Authors:  Charles A Karcutskie; Arjuna Dharmaraja; Jaimin Patel; Sarah A Eidelson; Anish B Padiadpu; Arch G Martin; Gabriel Lama; Edward B Lineen; Nicholas Namias; Carl I Schulman; Kenneth G Proctor
Journal:  JAMA Surg       Date:  2018-02-01       Impact factor: 14.766

10.  Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity.

Authors:  Andrew Freeman; Tuesdy Horner; Robert C Pendleton; Matthew T Rondina
Journal:  Am J Hematol       Date:  2012-05-06       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.